Common side effects reported in trials include: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite Abdominal discomfort or bloating These effects are generally dose-dependent and tend to improve over time as the body adapts to the medication
Hormonal adjustment plays a parallel roleyour insulin sensitivity and blood sugar regulation stabilize within 46 weeks, eliminating the fatigue and headaches that often accompany rapid glucose shifts
Biosimilars must demonstrate comparable quality, safety, and efficacy to the reference product through a comprehensive comparability exercise, not just bioequivalence as with conventional generic medications
Rybelsus is the worlds first and only oral formulation of semaglutide, a medication belonging to the GLP-1 receptor agonist class
Update on MHRA safety review of medicines containing pseudoephedrine
Some participants experienced increased aggression or agitation, but these were infrequent and comparable to placebo groups